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Abstract
Dengue hemorrhagic fever is an acute infectious disease caused by dengue virus. We described the
high-resolution CT findings in a 70-year-old male with the disease, which was diagnosed by clinical
examination and confirmed by serological methods. High-resolution CT demonstrated bilateral
areas of consolidation with air bronchogram and ground glass opacities, as well as small bilateral
pleural effusions. Dengue hemorrhagic fever should be considered in the differential diagnosis of
diffuse pulmonary hemorrhage.
Background
Dengue fever (DF) is an acute infectious disease caused by
dengue virus (DENV). It is a mosquito-borne flavivirus
that belongs to the family Flaviviridae, and consists of four
distinct serotypes (DENV 1–4) [1,2]. Dengue virus causes
disease in humans, including dengue fever, dengue hem-
orrhagic fever (DHF) and dengue shock syndrome (DSS)
[1,2]. The virus is transmitted to humans by the bite of
infected female mosquitoes of the genus Aedes. Dengue
disease has a wide spectrum of clinical signs and symp-
toms, ranging from asymptomatic infection to severe and
lethal manifestations [3]. However, pulmonary hemor-
rhage and hemoptysis have been rarely described in the
literature [4,5].
The prevalence of dengue infection has grown dramati-
cally in recent decades, and the disease is now endemic in
more than 100 countries in Africa, the Americas, the East-
ern Mediterranean, Southeast Asia and the Western Pacific
[6,7]. The global resurgence of dengue is thought to be
due to failure to control the Aedes populations, uncon-
trolled urbanization, population growth, climate change,
and increasing number of international travelers [8].
In a review of the literature, we have found only one
report describing the high resolution computed tomogra-
phy (HRCT) findings in DHF [4]. The purpose of this
study was to describe the high-resolution CT findings in a
patient with dengue hemorrhagic fever, who presented
with pulmonary hemorrhage and massive hemoptysis.
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Case presentation
A 70-year-old male presented to the Emergency Depart-
ment with massive hemoptysis for the last 6 hours, respi-
ratory distress, anemia, hemodynamic instability, and
renal failure. He had a 6-day history of fever, intense head-
ache, retro-orbital pain, arthralgia, myalgias, and dry
cough. There were no gastrointestinal complaints. Sup-
portive measures were taken and the patient was admitted
to the intensive care unit (ICU) and placed on mechanical
ventilatory support. On examination, he appeared anx-
ious, pale and dyspneic, and inspection revealed ecchy-
moses over his arms and abdomen. His vital signs
included a tachycardia of 110 beats/min (bpm), a respira-
tory rate of 32 breaths/min, a blood pressure of 90/50
mmHg, and normal temperature (36.8°C). Fine bibasilar
crackles were present bilaterally. The remainder of the
physical examination was unremarkable. Laboratory eval-
uation revealed a red blood cell (RBC) count of 2.53 ×
106/mm3, hemoglobin level of 8.1 g/dL, hematocrit of
23.5% and platelet count of 50 × 103/mm3. His WBC
count was 4.1 × 103/mm3, with a normal differential.
Serum creatinine was 2.4 mg/dL, urea, 90 mg/dL, sodium,
135 mEq/L, aspartate aminotransferase, 30 U/L, alanine
aminotransferase, 40 U/L, alkaline phosphatase, 200 U/L,
gamma-glutamyl transpeptidase, 50 U/L, albumin, 2.5 g/
dL, and globulin, 2.4 g/dL. Prothrombin time (PT) was
16.6s (65%) and international normalized ratio (INR)
was 1.4. Arterial gasometry showed metabolic acidosis.
Chest radiograph demonstrated bilateral condensations,
and HRCT revealed large areas of consolidation and
ground glass attenuation in both lungs, predominantly in
the right lung, and small bilateral pleural effusions (Figure
1 and Figure 2). The patient then underwent bronchofi-
broscopy, which showed the presence of blood tinged
secretion coming from both lungs, and friable mucosa
with bleeding on touch. Lung biopsy was not performed
because of coagulation abnormalities. Dengue serology,
determined using a dengue IgM capture ELISA assay
(MAC-ELISA), was positive. The patient required several
blood transfusions, but developed refractory shock, severe
metabolic acidosis, and died 15 days after admission.
Discussion
The clinical presentations of dengue include non-specific
febrile illness, dengue fever, dengue hemorrhagic fever,
and dengue shock syndrome. Dengue fever usually
presents as an acute fever with headache, rash, myalgia,
retro-orbital pain, arthralgia, prostration, lymphadenopa-
thy, and leucopenia [8,9]. In general, laboratorial findings
include neutropenia followed by lymphocytosis, presence
of atypical lymphocytes and thrombocytopenia [9]. Virus
can be detected in blood for 4 or 5 days after the onset of
symptoms and then disappears as antibody (immu-
noglobulin M [IgM]) production increases. In primary
infections, IgG antibody appears within a few days,
whereas in secondary infections, the IgG level rises imme-
diately after the onset of symptoms and remains high in
most patients [8].
Early diagnosis of DV infection is important and can be
provisionally established by clinical observation and eas-
ily available laboratory tests. The presence of high fever of
acute onset associated with a positive tourniquet test and
hemoconcentration (increase of the hematocrit of 20% or
more) or thrombocytopenia are sufficient to establish a
HRCT showing extensive areas of consolidation with air  bronchogram and ground glass opacities in both lungs, pre- dominantly in the right lung Figure 1
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HRCT showing extensive areas of consolidation with air  bronchogram and ground glass opacities in both lungs, pre- dominantly in the right lung Figure 2
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provisional diagnosis of DHF, but a negative tourniquet
test does not rule out dengue infection. Low platelet
counts do not predict clinically significant bleeding in
dengue, and DHF or dengue shock syndrome cases fre-
quently have compensated consumptive coagulopathy
that seldom requires treatment [7]. Therefore, platelet or
blood transfusions are only indicated in cases where coag-
ulopathy causes massive bleeding [10]. Currently, dengue
diagnosis is based on serology, viral isolation and RNA
detection. Enzyme-linked immunosorbent assays (ELISA)
are still the most widely used technique for serological
diagnosis, but they do not identify the dengue virus sero-
type responsible for the current infection [11].
According to WHO guidelines [10], our patient showed
the criteria for defining a case of DHF, since he presented
all of the following signs and symptoms: fever lasting 2–7
days; hemorrhagic tendencies, evidenced by the presence
of ecchymoses and bleeding from the respiratory tract
(hemoptysis); thrombocytopenia less than 100,000 cells
per mm3; and evidences of plasma leakage, manifested by
pleural effusion and hypoproteinaemia. Other manifesta-
tions of dengue fever were also present, including head-
ache, myalgia, arthralgia, leucopenia and a positive IgM
antibody test.
Dengue hemorrhagic fever is characterized by an increase
in capillary permeability, which results in fluid extravasa-
tions (pleural effusion, ascites), and haemostatic changes,
including decreased platelet levels near the time of defer-
vescence and hemorrhagic manifestations [2,9]. Major
hemorrhage is unusual except when in association with
profound or prolonged shock [6]. The liver may be
enlarged and serum activity of aminotransferases is usu-
ally increased [12]. DHF can also progress to DSS, which
is associated with hypotension caused by severe plasma
leakage [2,12].
Thoracic manifestations such as pleural effusion and
pneumonitis, are uncommon in DHF, and pulmonary
hemorrhage is even more rare. Hemoptysis has been
reported in 1.4% of dengue infections. The pathogenesis
of bleeding in DHF patients is not well understood. It is
thought to be a multifactorial process with abnormalities
in the coagulation cascade, thrombocytopenia, platelet
dysfunction, disseminated intravascular coagulation, and
vascular defects. Vascular permeability has been thought
to be mediated by histamine release [4,5]. Our patient
presented with hemoptysis, and, for this reason, he under-
went HRCT for the investigation of pulmonary hemor-
rhage. HRCT revealed extensive areas of consolidation
with air bronchogram and ground glass opacities in both
lungs, predominantly in the right lung, and small bilateral
pleural effusions. By contrast, the only report of the HRCT
findings found in the literature described the presence of
discrete patchy ground glass opacities in both lungs,
which regressed after conservative treatment.
Morphological studies of lung tissues revealed interstitial
pneumonia associated with focal or diffuse zones of alve-
olar congestion and hemorrhage, increase of alveolar
macrophages number, recruiting of platelets, mononu-
clear, and polymorphonuclear cells [3,12].
There is no specific treatment for dengue fever. However,
careful clinical management frequently saves the lives of
DHF patients. With appropriate intensive supportive ther-
apy, mortality may be reduced to less than 1 per cent [7].
Conclusion
In conclusion, dengue hemorrhagic fever should be con-
sidered in the differential diagnosis of a patient with fever,
hemoptysis, and diffuse pulmonary infiltration. The high-
resolution CT findings of dengue hemorrhagic fever con-
sist of bilateral areas of consolidation with air broncho-
gram and ground-glass opacities, and bilateral pleural
effusions.
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